Category Archives: Public Policy

Latest From Public Policy

BIO Strongly Supports R&D Tax Credit Legislation

cells115x76

The House Ways and Means Committee posted the following message on its home page showing the support of several organizations, including BIO, for the American Research & Competitiveness Act (H.R. 4438): “Today, the National Association of Manufacturers, Chamber of Commerce, R&D Credit Coalition, and Biotechnology Industry Organization – representing thousands of small and large U.S. businesses – issued their support for H.R. 4438, a bipartisan, permanent extension of the research and development (R&D) tax credit. In their call for a permanent R&D Read More >

Business and Investments, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Building the Bioeconomy

Building-the-Bioeconomy

Leaders across the globe have increasingly begun to target the bioscience industry as an economic engine that provides high wage, high-skilled jobs across a broad range of occupations. During the last decade, this understanding of the economic potential of the industry has led to policies and programs that provide supportive tax environments in capital formation, technology transfer, and funding for a workforce to facilitate research, development, and manufacturing. BIO has just released a first-of-its-kind report Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , ,

STEM Video Competition Offers Cash Award

STEM-video-competition

Budding scientists, take note. Biocom Institute and the Coalition of State Bioscience Institutes have extended the deadline for an online STEM video competition. The competition is open to all United States students in grades 5-12. The students will be required to create a one-minute video designed to answer one of two questions – Why is STEM important to YOU? or Who is your STEM hero and why? Video submissions should be uploaded to YouTube and Read More >

Events, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Indiana Governor Signs Bill that Supports Transparent Communication

admin-ajax copy

Indiana Governor Mike Pence has signed bipartisan legislation enabling retail pharmacies within his state to substitute interchangeable biologic medicines, once approved, for the innovator drug on which they are based. Not only does this legislation empower pharmacists to use their professional discretion to automatically substitute interchangeable biologic medicines, it also ensures transparent communication within a patient’s entire health care team to ensure the best decisions possible. The newly signed Senate Bill 262 ensures pharmacists communicate with the Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Corporate-Sponsored University Research Valuable for Further Innovation

SBIR Reauthorization Moves Forward

New research published in Nature, Technology Transfer: Industry-funded academic inventions boost innovation, provides data undermining “assumptions that corporate-funded academic research is less accessible and useful to others.” After reviewing empirical evidence covering 20 years of inventions in the University of California system the authors find that: “Corporate-sponsored research is surprisingly valuable for further innovation. Data collected over 20 years at nine campuses and three national laboratories administered by the University of California show that corporate-sponsored Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,